Finanzwire Finanzwire
Basculer en Français
10099 Companies
206760 Keywords
136906 Articles
109581 Press releases
Headlines Articles Press releases Relief Therapeutics Holding SA Remove
  1. Home
  2. Companies
  3. Relief Therapeutics Holding SA
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/04/2024 at 07:05, 1 year 5 months ago

    Relief Therapeutics Reports Positive Study Results for Phenylketonuria Treatment

    Relief Therapeutics RLF-OD032 Phenylketonuria Sapropterin Dihydrochloride Clinical Study Results
  • PRESS RELEASE

    published on 10/04/2024 at 07:00, 1 year 5 months ago

    Relief Therapeutics Reports Positive Results from RLF-OD032 Proof-of-Concept Clinical Study for Phenylketonuria

    Relief Therapeutics reports positive results from RLF-OD032 proof-of-concept clinical study for Phenylketonuria, showing bioequivalence with KUVAN(R) in managing PKU. RLF-OD032 aims to offer a patient-friendly, portable solution for PKU treatment
    Clinical Study Relief Therapeutics RLF-OD032 Bioéquivalence Phenylketonuria
    Logo of Relief Therapeutics Holding SA
  • BRIEF

    published on 09/23/2024 at 07:05, 1 year 6 months ago

    Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement

    FDA Approval Relief Therapeutics Milestone Payment Niemann-Pick Disease SWK Funding
  • PRESS RELEASE

    published on 09/23/2024 at 07:00, 1 year 6 months ago

    Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement

    Relief Therapeutics announced $2 million milestone payment under royalty sales agreement after FDA approval of arimoclomol for Niemann-Pick Disease Type C treatment
    FDA Approval Relief Therapeutics Milestone Payment Arimoclomol Royalty Sales Agreement
    Logo of Relief Therapeutics Holding SA
Previous page
1 ... 6 7
Accesswire
  • Published on 03/26/2026 at 14:05, 33 minutes ago

    SouthGobi Announces Profit Warning

  • Published on 03/26/2026 at 13:00, 1 hour 38 minutes ago

    Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor

  • Published on 03/26/2026 at 13:00, 1 hour 38 minutes ago

    GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle

  • Published on 03/26/2026 at 12:59, 1 hour 39 minutes ago

    Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance

  • Published on 03/26/2026 at 12:45, 1 hour 53 minutes ago

    Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia

View all ACCESSWIRE
EQS Group
  • Published on 03/26/2026 at 14:20, 18 minutes ago

    Hotel Sacher Vienna celebrates its 150th anniversary - with sculptures by Erwin Wurm

  • Published on 03/26/2026 at 14:18, 20 minutes ago

    RHÖN-KLINIKUM AG with consistent development in financial year 2025

  • Published on 03/26/2026 at 14:14, 24 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Beazley plc

  • Published on 03/26/2026 at 14:13, 25 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Schroders plc

  • Published on 03/26/2026 at 14:12, 26 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Just Group plc

View all EQS
Les Echos
  • Published on 03/26/2026 at 08:57, 5 hours 41 minutes ago

    Edenred statement

  • Published on 03/26/2026 at 07:30, 7 hours 8 minutes ago

    BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY

  • Published on 03/25/2026 at 18:53, 19 hours 45 minutes ago

    LNA SANTE : 2025 Annual Results

  • Published on 03/25/2026 at 18:31, 20 hours 7 minutes ago

    Strong investment performance and active roll-out of our strategy

  • Published on 03/25/2026 at 17:45, 20 hours 53 minutes ago

    Combined General Meeting on May 05, 2026: publication of the notice of Meeting

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy